Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis
New pharmacologic advances in the treatment of diabetes include SGLT-2 inhibitors, which have been demonstrated in randomized-controlled clinical trials to reduce overall and cardiac-specific mortality and slow progression of chronic kidney disease. Euglycemic diabetic ketoacidosis is a rare but lif...
Enregistré dans:
Auteurs principaux: | Clara M. Gomez-Sanchez, MD, Bian X. Wu, MD, Jeffrey E. Gotts, MD, Robert W. Chang, MD |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3006de9df1f84acda593c0de6bbb7600 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Second line therapy in type 2 diabetes: legacy effect activation
par: Ekaterina A. Shestakova
Publié: (2017) -
Acidosis renal y diabetes insípida
par: SILVA,GABRIEL
Publié: (1956) -
Encefalomiopatia mitocondrial, acidosis lactica y apariencia de accidentes vasculares cerebrales
par: Mesa L,Tomas, et autres
Publié: (1990) -
Ruminal acidosis: strategies for its control
par: Jaramillo-López,Esaúl, et autres
Publié: (2017) -
Acidosis tubular renal: Presentación de 2 casos clínicos
par: OCHOA,EDECIA, et autres
Publié: (1975)